ATAZANAVIR
- Product NDC
- 70771-1591
- 11-digit product format
- 707711591
- Labeler code
- 70771
- Product ID
- 70771-1591_7d41e669-d7c9-44b9-9470-793e56fa1776
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATAZANAVIR
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA210575
- Marketing category
- ANDA
- Marketing start
- 2021-05-04
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70771-1591 | ATAZANAVIR CAPSULE [ZYDUS LIFESCIENCES LIMITED] | 2 | Legacy NDC | 20221015_59417e87-cf46-4db6-975b-daf9c921098f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1591-1 | 70771159101 | 100 CAPSULE in 1 BOTTLE (70771-1591-1) | 100 capsule | 2021-05-04 | 0000-00-00 | No | No | Current |
| 70771-1591-6 | 70771159106 | 60 CAPSULE in 1 BOTTLE (70771-1591-6) | 60 capsule | 2021-05-04 | 0000-00-00 | No | No | Current |